Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Federal University of the Valleys of Jequitinhonha and Mucuri | OTHER |
| Medical Research Council | OTHER_GOV |
| University of Southampton | OTHER |
Not provided
Not provided
Not provided
Hypertension and diabetes mellitus (DM) are highly prevalent in low and middle-income countries, and the proportion of patients with uncontrolled diseases is higher than in high income countries. Innovative strategies are required to surpass barriers of low sources, distance, and quality of healthcare. Our aim is to assess the uptake and effectiveness of the implementation of an integrated multidimensional strategy in the primary care setting, for the management of patients with hypertension and diabetes mellitus (DM) in Brazil. This is a scale up implementation study that has mixed-methods, and comprehends four steps: (1) needs assessment, including a standardized structured questionnaire and focus groups with healthcare practitioners; (2) baseline period, three months before the implementation of the intervention; (3) cluster randomized controlled trial (RCT) with a 12-month follow-up period; and (4) a qualitative study after the end of follow-up. The cluster RCT will randomize 35 centres to intervention (n= 18) or usual care (n= 17). Patients ≥18 years-old, with diagnosis of hypertension and/or DM, of five Brazilian cities in a resource-constrained area will be enrolled. The intervention consists of a multifaceted strategy, with a multidisciplinary approach, including telehealth tools (decision support systems, short message service, telediagnosis), continued education with an approach to issues related to the care of people with hypertension and diabetes in primary care, including pharmacological and non-pharmacological treatment and behavioural change. The project has actions focused on professionals and patients.
This scale up implementation study has mixed-methods, and comprehends four steps: (1) needs assessment, (2) baseline period, (3) cluster RCT and (4) qualitative study. The RE-AIM planning and evaluation framework will be used in this research project, which includes: reach (R), efficacy (E), adoption (A), implementation (I), and maintenance (M). The Adaptation Framework might be used as well, in case adaptations need to be conducted during the intervention, taking into account the COVID-19 pandemic and possible new waves.
To calculate the sample size, the investigators took into account the proportion of patients with controlled hypertension (33%) and DM (37%) observed at baseline in the pilot study (data not published), and an absolute increase of 6% in these proportions one year after the implementation of the intervention, with a power of 0.80, level of significance of 0.05 and intra cluster correlation coefficient of 0.026. The calculated sample was 34 primary care centres, 17 in each arm, with a minimum of 148 participants in each centre. As the total number of primary care centres in the five municipalities is 35, the investigators planned to include one extra unit in the intervention arm. Taking into account a drop out rate of up to 17.8%, the total number of included individuals will be 180.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Eighteen primary care centers will be randomized to the intervention arm, which consists of a multidimensional strategy, with a multidisciplinary approach, for the management of patients with hypertension and diabetes in the primary care setting. It is going to include:
|
|
| Usual care | No Intervention | Seventeen primary care centers will be randomized to usual care. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Multidimensional intervention | Other | Multidimensional intervention, with mutidisciplinary approach. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Composite outcome of proportion of patients with controlled disease | (i) for hypertension, the proportion (%) of patients with systolic blood pressure (SBP) <140 mmHg and diastolic blood pressure (DBP) < 90 mmHg; (ii) for diabetes, the proportion (%) of patients with glycohemoglobin ≤ 7% if the age < 60 years, or < 8% if the age is ≥ 60 years; (iii) for those with both hypertension and diabetes, proportion (%) of patients with both diseases controlled. | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of patients with controlled hypertension | The proportion (%) of patients with systolic blood pressure (SBP) <140 mmHg and diastolic blood pressure (DBP) < 90 mmHg | 12 months |
| Proportion of patients with controlled diabetes |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of patients who participated in group activities in 12 months. | Percentage of patients with hypertension and diabetes who participated at least once in group activities in 12 months. | 12 months |
| Total follow-up time of patients |
Inclusion Criteria:
Primary Health Care - Basic health unit with internet availability and complete team, including a Brazilian doctor or with a proficiency test in the Portuguese language.
Patients
- Adult patients (from 18 years-old), diagnosed with hypertension and/or DM, registered in the medical record.
Subproject cluster randomised controlled trial. All of the above criteria and the following additional criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Federal University of Minas Gerais | Belo Horizonte | Minas Gerais | 30130-100 | Brazil |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37044364 | Derived | Fonseca SF, Ribeiro ALP, Cimini CCR, Soares TBC, Delfino-Pereira P, Nogueira LT, Moura RMF, Motta-Santos D, Ribeiro LB, Camargos MCS, Paixao MC, Pires MC, Batchelor J, Marcolino MS. Scale up of implementation of a multidimensional intervention to enhance hypertension and diabetes care at the primary care setting: A protocol for a cluster-randomized study in Brazil. Am Heart J. 2023 Aug;262:119-130. doi: 10.1016/j.ahj.2023.04.006. Epub 2023 Apr 11. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
Cluster randomized controlled trial.
Not provided
Not provided
Not provided
Not provided
The proportion (%) of patients with glycohemoglobin ≤ 7% if the age < 60 years, or < 8% if the age is ≥ 60 years
| 12 months |
| Change in blood pressure | The mean difference in delta SBP and DBP (mmHg) in patients with hypertension, when comparing the intervention and the control groups, in 12 months | 12 months |
| Change in glycohemoglobin | The mean difference in delta glycohemoglobin (%) in patients with diabetes, when comparing the intervention and the control groups, in 12 months | 12 months |
| Number of blood pressure measurements | Number of blood pressure measurements per patient with hypertension in 12 months | 12 months |
| Number of glycohemoglobin measurements | Number of glycohemoglobin measurements per patient with diabetes in 12 months | 12 months |
Time in months between the first consultation after enrollment and last consultation during the study period
| 12 months |
| Number of consultations during the follow-up time | Number of consultations with medical doctors and nurses during the follow-up time | 12 months |
| Performance in the 2-minute standing gait test | The difference in the number of steps (delta from the beginning) in the 2-minute standing gait test within 6 months and 12 months. | 6 and 12 months |
| Performance in the hand grip strength test | The difference in the hand grip strength measured by in kgf (delta from the beginning) within 6 months and 12 months. | 6 and 12 months |
| Change in the body weight | The change in the body weight (kg) in the follow-up time | 12 months |
| Change in the body mass index | The change in the body mass index in the follow-up time | 12 months |
| Change in the waist circumference | The change in the waist circumference (cm) in the follow-up time | 12 months |
| Program adherence | Total follow-up time (time between the first consultation after enrollment and last consultation); median time between medical and nurse consultations; number of consultations during follow-up time, number of groups conducted at each primary care centre during the follow-up; participation of patients at the educational groups; adherence to CDSS recommendations (intervention group only). | 12 months |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |